Clinical trials
Triple Negative Breast Neoplasms trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 7 |
| Universidad Nacional de Colombia | 3 |
| Hoffmann-La Roche | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Fundación Santa Fe de Bogota | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 16 |
| Breast Neoplasms | 6 |
| Ovarian Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Diseases | 1 |
| COVID-19 | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.